Skip to content
An Initiative of AVAC
Search
Back to Resource Library

HIV Self-Testing and PrEP: Opportunities for scale-up

6 September 2024

This brief addresses common misconceptions about the use of HIV self-testing (HIVST) for PrEP initiation and continuation while highlighting the opportunities that HIVST can provide in order to support further scale-up of this important self-care option.

Topic(s): Normative Guidance/Policies, Research, Service Delivery, Testing

Product(s): Dapivirine Vaginal Ring, Oral PrEP

Format(s): Factsheet

Source(s): AVAC and WHO

Type: Document

Download

Featured Resources

External Link

PrEP Method Switching: Will it Yield Greater Coverage of HIV Protection? Applying Lessons Learned from Family Planning to Guide Future Research in the Context of PrEP Choice

This review from Current HIV/AIDS Reports draws parallels between HIV prevention and family planning by summarizing how method choice and product switching affected contraceptive coverage globally, synthesizes what is known about PrEP product switching, and outlines evidence gaps to help guide future research on PrEP switching in the context of choice.
Spreadsheet

2024 Q2 Global PrEP Tracker

AVAC’s Global PrEP Tracker offers two views on PrEP uptake around the world. Visit data.prepwatch.org for a dynamic map-based tool to explore trends in oral PrEP use globally as countries introduce and scale up PrEP programs. For insights on the full scope of PrEP use around the world, the PrEP Tracker as a spreadsheet offers…
Document

PURPOSE 1 Summary

This factsheet provides a summary of the PURPOSE 1 phase III clinical trial of lenacapavir for PrEP and F/TAF for cisgender women taking place in South Africa and Uganda.
External Link

Client Experiences with “Dynamic Choice Prevention,” a Model for Flexible Patient-centred HIV Prevention Delivery in Rural Eastern Africa

This article from Journal of the International AIDS Society discusses client experiences of a dynamic choice model for HIV prevention piloted in Kenya and Uganda under the SEARCH study, where clients were supported to select HIV prevention method, testing mode, and service delivery channel from a range of options.
Document

Online Pharmacy PrEP and PEP: Technical considerations and learnings from Kenya

This document, developed by PATH, is intended as a how-to implementation guide for providing oral pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) via online pharmacy service delivery (ePrEP/ePEP) based on learnings and evidence from the ePrEP Kenya pilot study that ran from October 2022 through July 2024. The guide was developed to support ministries of…
External Link

Women’s Preferences for HIV Prevention Service Delivery in Pharmacies during Pregnancy in Western Kenya: A discrete choice experiment

This article from Journal of the International AIDS Society describes the results of a discrete choice experiment to evaluate where and how pregnant and lactating people in western Kenya preferred to access HIV prevention services, including PrEP.
External Link

Investigating the Effectiveness of Web-based HIV Self-test Distribution and Linkage to HIV Treatment and PrEP among Groups at Elevated Risk of HIV in Viet Nam Provinces: A mixed-methods analysis of implementation from pilot to scale-up

This article from Journal of the International AIDS Society describes the impact of a web-based HIV self-testing intervention, including linking those who tested negative to PrEP services, in Vietnam.
Document

Pre-Exposure Prophylaxis and Adolescent Girls and Young Women in Eastern and Southern Africa: The latest insights

Eastern and southern Africa (ESA) is the world’s most heavily HIV-impacted region, with adolescent girls and young women (AGYW) disproportionately affected. To support the scale-up of PrEP amongst AGYW in ESA, in September 2021 UNICEF and partners released the implementation brief “Improving the Quality of Pre-Exposure Prophylaxis Implementation for Adolescent Girls and Young Women in…
External Link

WHO Implementation Tool for Pre-Exposure Prophylaxis (PrEP) of HIV Infection

The WHO has developed this series of modules to support the implementation of PrEP among a range of populations in different settings.
External Link

Low Selection of HIV PrEP Refills at Private Pharmacies among Clients who Initiated PrEP at Public Clinics: Findings from a mixed-methods study in Kenya

This article from BMC Health Services Research describes the impact of a pilot project to permit oral PrEP users to obtain refills at private pharmacies for an additional fee.